GENZYME CARTICEL BLA APPROVAL WILL BOOST INSURANCE COVERAGE, PRODUCT SALES, COMPANY SAYS; FDA REQUIRES POSTMARKET STUDIES TO EVALUATE LONG-TERM EFFICACY